Silence Therapeutics Plc (SLN)
Silence Therapeutics - Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’Option to Purchase Additional ADSs
Silence Therapeutics - Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’Option to Purchase Additional ADSs
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical